Summary
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Market Segment as follows:
By Type
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
By Application
VTE
ACS/MI
AF
Others
By Company
Bayer
Sanofi
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Platelet aggregation inhibitors (PAI)
1.1.2.2 Low-molecular-weight Heparin (LMWH)
1.1.2.3 Direct thrombin inhibitor (DTI)
1.1.2.4 Direct factor Xa inhibitors (DFXa)
1.1.2.5 Vitamin K antagonists (VKA)
1.1.2.6 Others
1.1.3 Market by Application
1.1.3.1 VTE
1.1.3.2 ACS/MI
1.1.3.3 AF
1.1.3.4 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Bayer
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Sanofi
6.3 Boehringer Ingelheim
6.4 Johnson & Johnson
6.5 Genentech (Roche)
6.6 AstraZeneca
6.7 Bristol-Myers Squibb
6.8 Aspen
6.9 Lilly
6.10 Otsuka
6.11 Pfizer
6.12 Daiichi Sankyo
6.13 The Medicines Company
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Platelet aggregation inhibitors (PAI) Market Size and CAGR 2013-2018 (Million USD)
Figure Platelet aggregation inhibitors (PAI) Market Size and CAGR 2013-2018 (Volume)
Figure Platelet aggregation inhibitors (PAI) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Platelet aggregation inhibitors (PAI) Market Forecast and CAGR 2019-2025 (Volume)
Figure Low-molecular-weight Heparin (LMWH) Market Size and CAGR 2013-2018 (Million USD)
Figure Low-molecular-weight Heparin (LMWH) Market Size and CAGR 2013-2018 (Volume)
Figure Low-molecular-weight Heparin (LMWH) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Low-molecular-weight Heparin (LMWH) Market Forecast and CAGR 2019-2025 (Volume)
Figure Direct thrombin inhibitor (DTI) Market Size and CAGR 2013-2018 (Million USD)
Figure Direct thrombin inhibitor (DTI) Market Size and CAGR 2013-2018 (Volume)
Figure Direct thrombin inhibitor (DTI) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Direct thrombin inhibitor (DTI) Market Forecast and CAGR 2019-2025 (Volume)
Figure Direct factor Xa inhibitors (DFXa) Market Size and CAGR 2013-2018 (Million USD)
Figure Direct factor Xa inhibitors (DFXa) Market Size and CAGR 2013-2018 (Volume)
Figure Direct factor Xa inhibitors (DFXa) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Direct factor Xa inhibitors (DFXa) Market Forecast and CAGR 2019-2025 (Volume)
Figure Vitamin K antagonists (VKA) Market Size and CAGR 2013-2018 (Million USD)
Figure Vitamin K antagonists (VKA) Market Size and CAGR 2013-2018 (Volume)
Figure Vitamin K antagonists (VKA) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Vitamin K antagonists (VKA) Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure VTE Market Size and CAGR 2013-2018 (Million USD)
Figure VTE Market Size and CAGR 2013-2018 (Volume)
Figure VTE Market Forecast and CAGR 2019-2025 (Million USD)
Figure VTE Market Forecast and CAGR 2019-2025 (Volume)
Figure ACS/MI Market Size and CAGR 2013-2018 (Million USD)
Figure ACS/MI Market Size and CAGR 2013-2018 (Volume)
Figure ACS/MI Market Forecast and CAGR 2019-2025 (Million USD)
Figure ACS/MI Market Forecast and CAGR 2019-2025 (Volume)
Figure AF Market Size and CAGR 2013-2018 (Million USD)
Figure AF Market Size and CAGR 2013-2018 (Volume)
Figure AF Market Forecast and CAGR 2019-2025 (Million USD)
Figure AF Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Anticoagulants Market Size and CAGR 2013-2017 (Million USD)
Figure Global Anticoagulants Market Size and CAGR 2013-2017 (Volume)
Figure Global Anticoagulants Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Anticoagulants Market Forecast and CAGR 2019-2025 (Volume)
Figure China Anticoagulants Market Size and CAGR 2013-2017 (Million USD)
Figure China Anticoagulants Market Size and CAGR 2013-2017 (Volume)
Figure China Anticoagulants Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Anticoagulants Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Anticoagulants SWOT List
Figure Anticoagulants Porter's Five Forces
